482 results on '"Lambert, Michele P"'
Search Results
2. Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia
3. Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC
4. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome
5. Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management
6. Defective RAB31-mediated megakaryocytic early endosomal trafficking of VWF, EGFR, and M6PR in RUNX1 deficiency
7. An update on pediatric ITP: differentiating primary ITP, IPD, and PID
8. Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel
9. Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method
10. Human mutational constraint as a tool to understand biology of rare and emerging bone marrow failure syndromes
11. Mini-clusters of postadenovirus VITT
12. Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction
13. What is in a name: defining pediatric refractory ITP
14. Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the BAT-LAB substudy): communication from the Platelet Physiology ISTH-SSC
15. AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
16. Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes
17. Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor
18. 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia
19. Eltrombopag for use in children with immune thrombocytopenia
20. Evaluating the clinical validity of genes related to hemostasis and thrombosis using the ClinGen gene curation framework
21. Clinical updates in adult immune thrombocytopenia
22. Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease
23. A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss
24. A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders
25. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine
26. Chemotherapy induced thrombocytopenia in pediatric oncology
27. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
28. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome
29. A case-control study of bleeding risk in children with 22q11.2 deletion syndrome undergoing cardiac surgery.
30. Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia
31. Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
32. Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syndrome in B-Cell ALL Patients Receiving CART19
33. Quantification of Neutrophil Extracellular Traps (NETs) in Pediatric Patients with COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) through Plasma and Peripheral Smear Analysis
34. Analysis of Clinical Cytokine Panel Profiles As Diagnostic and Prognostic Biomarkers in Pediatric Hyperinflammatory Conditions
35. Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression
36. Challenges and promises for the development of donor-independent platelet transfusions
37. Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders
38. A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation
39. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
40. Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19
41. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients
42. Dose Escalation Trial of Desulfated Heparin (ODSH) in Septic Peritonitis
43. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion
44. Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor–related protein 1 (LRP1) on megakaryocytes
45. Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression.
46. Population based frequency of naturally occurring loss‐of‐function variants in genes associated with platelet disorders
47. Premedication with Hydrocortisone Increases Risk of Adverse Drug Events and Return to Medical Care Among Pediatric Patients with ITP Treated with IVIG
48. Pediatric Patients with Immune Thrombocytopenic Purpura Have a Dysbiotic Gut Microbiome at Time of Diagnosis
49. Immature Platelet Fraction Does Not Correlate with Treatment Response in Immune Thrombocytopenia
50. The Role of PF4 Antibodies in Pediatric Sars-Cov-2 Infections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.